dc.contributor.author | Arana Urbieta, Lide | |
dc.contributor.author | Bayón Cordero, Laura | |
dc.contributor.author | Sarasola Telleria, Laura Isabel | |
dc.contributor.author | Berasategi, Miren | |
dc.contributor.author | Ruiz, Sandra | |
dc.contributor.author | Alcorta Calvo, Miren Itziar | |
dc.date.accessioned | 2019-05-09T08:21:19Z | |
dc.date.available | 2019-05-09T08:21:19Z | |
dc.date.issued | 2019-03-20 | |
dc.identifier.citation | Nanomaterials 9(3) : (2019) // Article ID 464 | es_ES |
dc.identifier.issn | 2079-4991 | |
dc.identifier.uri | http://hdl.handle.net/10810/32715 | |
dc.description.abstract | Solid lipid nanoparticles (SLN) present low toxicity, versatility to incorporate both lipophilic and hydrophilic drugs, controlled drug release and they are easy to scale-up. It is well known that the endocytosis pathway by which SLN are taken up and the subsequent subcellular distribution are crucial for the biological effect of the incorporated drug. In addition, interactions between SLN and cells depend on many factors, such as, the composition of nanoparticle surface. In this work different amounts of phosphatidylethanolamine polyethylene glycol (PE-PEG) were added to SLN composed of stearic acid, Epikuron 200 and sodium taurodeoxycholate. Characterization of obtained nanoparticle suspensions were performed by the analysis of particle size, polydispersity index, zeta-potential, cell toxicity and cell internalization pathway. We have observed that the presence of PE-PEG improves active cell internalization of the nanoparticles in an oral adenocarcinoma cell line, reducing non-specific internalization mechanisms. Finally, we have tested the effect of surface coating on the efficiency of incorporated drugs using all-trans retinoic acid as a model drug. We have observed that delivery of this drug into PE-PEG coated SLN increases its chemotoxic effect compared to non-coated SLN. Therefore, it can be concluded that surface modification with PE-PEG improves the efficiency and the specificity of the SLN-loaded drug. | es_ES |
dc.description.sponsorship | This work was supported by grant ELKARTEK (2017) KK-2017/00008. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | MDPI | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.subject | solid lipid nanoparticles | es_ES |
dc.subject | phosphatidilethanolamine-polyethileneglycol | es_ES |
dc.subject | controlled drug delivery | es_ES |
dc.subject | cell internalization pathway | es_ES |
dc.subject | cytotoxicity | es_ES |
dc.subject | all-trans retinoic acid | es_ES |
dc.subject | drug-delivery | es_ES |
dc.subject | retinoic acid | es_ES |
dc.subject | gene delivery | es_ES |
dc.subject | transporters | es_ES |
dc.subject | endocytosis | es_ES |
dc.subject | formulation | es_ES |
dc.subject | mechanism | es_ES |
dc.subject | receptor | es_ES |
dc.subject | binding | es_ES |
dc.title | Solid Lipid Nanoparticles Surface Modification Modulates Cell Internalization and Improves Chemotoxic Treatment in an Oral Carcinoma Cell Line | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0). | es_ES |
dc.rights.holder | Atribución 3.0 España | * |
dc.relation.publisherversion | https://www.mdpi.com/2079-4991/9/3/464 | es_ES |
dc.identifier.doi | 10.3390/nano9030464 | |
dc.departamentoes | Bioquímica y biología molecular | es_ES |
dc.departamentoeu | Biokimika eta biologia molekularra | es_ES |